Updates are available Correction dated 2022-01-19
Click to view Correction: https://doi.org/10.1038/s41568-022-00445-6
-
Authors
- License Information
-
More Information
Article History
Accepted: 26 November 2021
First Online: 14 January 2022
Change Date: 19 January 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41568-022-00445-6
Competing interests
: T.J.C. and A.V.R.K. have filed a patent on using intracellular PDL1 to predict anticancer responses and drugs that reduce tumour PDL1 for treatment purposes.
